Evidence map›Paper›PMID 39015353›Full record

ArticleAnnual reports in medicinal chemistry2023

The challenges and opportunities of developing small molecule inhibitors of MraY.

Destinee Manning, Tzu-Yu Huang, Tomayo Berida, Sudeshna Roy

Abstract read
In one paragraph

Article in Annual reports in medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Destinee ManningDepartment of BioMolecular Sciences, University of Mississippi, University, MS, United States.
Tzu-Yu HuangDepartment of BioMolecular Sciences, University of Mississippi, University, MS, United States.
Tomayo BeridaDepartment of BioMolecular Sciences, University of Mississippi, University, MS, United States.
Sudeshna RoyDepartment of BioMolecular Sciences, University of Mississippi, University, MS, United States.

Funding

Target-based chemotherapeutics development against Mycobacterium tuberculosisR21AI142210 · NIAID · UNIVERSITY OF MISSISSIPPI · PI ROY, SUDESHNA · 2019 to 2020
$411k
Laser spectroscopic instrumentation for isotopic sensing of biogenic Nitric OxideR21GM103460 · NIGMS · PRINCETON UNIVERSITY · PI WYSOCKI, GERARD · 2012 to 2012
$190k
NIAID NIH HHS R21 AI142210NIGMS NIH HHS R21 GM103460
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39015353
PMCPMC11250723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.